We started by assessing CSPG4 mRNA expression level by utilizing a publicly available database (accession number GSE126698) [20] which includes human samples of anaplastic thyroid cancer (ATC), follicular thyroid carcinoma (FTC), papillary thyroid carcinoma (PTC), and normal thyroid tissues as control. The gene discussed is CSPG4; the disease is thyroid gland follicular carcinoma.